Ligand validation:4BC1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4BC1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BC1_NAG_B_701	21%	45%	0.179	0.79	0.47	1.62	-	3	0	0	100%	0.9333
4BC1_NAG_D_701	11%	37%	0.24	0.758	0.39	2.02	-	2	0	0	100%	0.9333
4BC1_NAG_D_702	7%	34%	0.327	0.783	0.54	2.01	-	2	0	0	100%	0.9333
4BC1_NAG_A_701	6%	59%	0.354	0.795	0.46	1.08	-	1	0	0	100%	0.9333
4BC1_NAG_D_703	4%	43%	0.357	0.745	0.6	1.59	-	3	0	0	100%	0.9333
4BC1_NAG_C_701	4%	54%	0.35	0.722	0.44	1.32	-	1	0	0	100%	0.9333
4BC1_NAG_B_702	2%	33%	0.494	0.761	0.49	2.13	-	2	0	0	100%	0.9333
2WHP_NAG_A_601	47%	54%	0.171	0.909	0.43	1.31	-	2	0	0	100%	0.6533
5EHQ_NAG_A_1503	34%	69%	0.19	0.871	0.41	0.79	-	1	0	0	100%	0.9333
5FKJ_NAG_D_560	26%	70%	0.18	0.821	0.53	0.62	-	1	0	0	100%	0.84
4A16_NAG_B_1546	25%	14%	0.167	0.816	1.18	2.66	1	7	5	0	93%	0.9333
4BC0_NAG_D_701	20%	50%	0.263	0.865	0.55	1.36	-	2	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.